Correlation Between Pfizer and Schwab International

Can any of the company-specific risk be diversified away by investing in both Pfizer and Schwab International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Schwab International into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Schwab International Equity, you can compare the effects of market volatilities on Pfizer and Schwab International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Schwab International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Schwab International.

Diversification Opportunities for Pfizer and Schwab International

0.05

Correlation Coefficient

Pfizer  Schwab International

Significant diversification

The 3 months correlation between Pfizer and Schwab is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Schwab International Equity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Schwab International and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Schwab International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Schwab International has no effect on the direction of Pfizer i.e., Pfizer and Schwab International go up and down completely randomly.

Pair Corralation between Pfizer and Schwab International

Considering the 90-day investment horizon Pfizer is expected to generate 20.69 times less return on investment than Schwab International. In addition to that, Pfizer is 1.38 times more volatile than Schwab International Equity. It trades about 0.01 of its total potential returns per unit of risk. Schwab International Equity is currently generating about 0.18 per unit of volatility. If you would invest  1,865  in Schwab International Equity on December 25, 2024 and sell it today you would earn a total of  170.00  from holding Schwab International Equity or generate 9.12% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.33%
Values	Daily Returns

Pfizer Inc  vs.  Schwab International Equity

Pfizer Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Schwab International

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Schwab International Equity are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady technical indicators, Schwab International may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Pfizer and Schwab International

The main advantage of trading using opposite Pfizer and Schwab International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Schwab International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Schwab International will offset losses from the drop in Schwab International's long position.

The idea behind Pfizer Inc and Schwab International Equity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.